ArticlePlant cell reports2026
CRISPR-Cas13-based amplification-free detection of three quarantine-significant sugarcane viruses.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Crop losses from viral pathogens cost billions of dollars annually, and sugarcane is particularly vulnerable. Sugarcane is the most cultivated crop in the world by volume; therefore, significant yield losses result in large dollar losses for farmers and trade economies. In some cases, viruses contribute to more than half of the yield reduction. Three quarantine-significant pathogens-Sugarcane mosaic virus (ScMV), Sugarcane streak mosaic virus (ScSMV), and Sugarcane yellow leaf virus (ScYLV)- pose major threats to global sugarcane production because of their rapid spread, asymptomatic infections, and delayed symptom expression. Effective management of these pathogens requires robust, rapid, and accurate detection methods that can distinguish among these viruses, even at low titers. Here, we report the development of an amplification-free CRISPR-Cas13-based assay with a limit of detection (LOD) of ~1.5 pM. The assay allows for simultaneous screening of all three viruses directly from bulk RNA extracts of plant material. Our approach leverages LwaCas13a specificity to detect and differentiate viral targets in a single assay. Compared with conventional multi-step assays, this strategy significantly reduces time and contamination risk. Validation on naturally infected material demonstrated its sensitivity and reliability. This platform provides a powerful tool for early and accurate diagnosis of ScMV, ScSMV, and ScYLV, with strong potential for integration into sugarcane virus surveillance and management programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.